Why might I have prostate tests?
You may have tests if you’re at higher risk of getting prostate cancer. In the UK, about 1 in 8 men will get prostate cancer at some point in their lives. And you’re more likely to get prostate cancer if you’re aged 50 or over, you’re black, or your father or brother has had it. You may also be at higher risk if your mother or sister has had breast cancer.
Your GP might also suggest having tests if you have symptoms of a prostate problem. Prostate problems can cause urinary symptoms, such as needing to rush to the toilet or needing to go more often than normal.
Urinary symptoms are usually caused by problems that aren’t cancer, such as an enlarged prostate or a urine infection. And most men with early prostate cancer don’t have any symptoms.
Prostate cancer that has spread to other parts of the body can cause weight loss and pain in the back, hips or pelvis. These symptoms are often caused by other problems. But it’s a good idea to get any symptoms checked out by your GP. They will want to make sure you get the right diagnosis so you can get the right treatment, if you need it.
What tests are done at the GP surgery?
There is no single test to diagnose prostate cancer. There are a few tests that your GP can do to find out if you have a prostate problem. The main tests include:
- a urine test to rule out a urine infection
- a prostate specific antigen (PSA) blood test
- a digital rectal examination (DRE).
Before you have these tests, your GP should explain what they involve and talk you through the advantages and disadvantages. They can help you understand more about prostate cancer and your own risk of getting it. It’s up to you whether you have the tests, so make sure you’ve got all the information you need, and give yourself time to think it through.
After you’ve had the tests, your GP will talk through the results with you. If they think you may have a prostate problem, they’ll make an appointment for you to see a specialist at a hospital.
What tests are done at the hospital?
At the hospital you will see a specialist, who will usually be a urologist or specialist nurse. You may have another PSA test or DRE.
The specialist will look at your:
They might recommend another PSA test at your GP surgery in the future. Or they might recommend further tests, including:
- an MRI (magnetic resonance imaging) scan
- a prostate biopsy
- a CT (computerised tomography) scan
- a bone scan – with or without X-rays.
You might also have a urine flow test and an ultrasound scan of your bladder. These are usually done to check for an enlarged prostate.
If you have a very high PSA level (for example, in the hundreds or thousands), you may have prostate cancer that has spread outside the prostate. So you might not need a biopsy. Instead, you may have a scan to show if there is cancer and see how far it has spread.
In some hospitals you might have a special type of MRI scan, called a multi-parametric MRI (mpMRI) scan, before having a biopsy. This can help your doctor see if there is any cancer inside your prostate, and how quickly any cancer is likely to grow. In other hospitals you may have a biopsy first.
If you’re worried about these tests or would like more information, speak to your doctor or nurse. Or you can speak to our Specialist Nurses.
Updated January 2019 | Due for Review January 2021
- Cancer Research UK. Prostate cancer incidence statistics: By Age [Internet]. 2017 [cited 2017 Feb 17]. Available from: www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/prostate-cancer/incidence#heading-One
- Cancer Research UK. Prostate cancer incidence statistics: Lifetime risk. [Internet]. 2010. Available from: www.cancerresearchuk.org/cancer-info/cancerstats/types/prostate/incidence/#Lifetime
- Chen Y-C, Page JH, Chen R, Giovannucci E. Family history of prostate and breast cancer and the risk of prostate cancer in the PSA era. The Prostate. 2008 Oct 1;68(14):1582–91.
- Hemminki K, Chen B. Familial association of prostate cancer with other cancers in the Swedish Family-Cancer Database. The Prostate. 2005 Oct 1;65(2):188–94.
- Ilic D, Neuberger MM, Djulbegovic M, Dahm P. Screening for prostate cancer. Cochrane Database Syst Rev. 2013;(1).
- Jones AL, Chinegwundoh F. Update on prostate cancer in black men within the UK. Ecancermedicalscience. 2014;8:455.
- Kiciński M, Vangronsveld J, Nawrot TS. An Epidemiological Reappraisal of the Familial Aggregation of Prostate Cancer: A Meta-Analysis. Little J, editor. PLoS ONE. 2011 Oct 31;6(10):e27130.
- Lloyd T, Hounsome L, Mehay A, Mee S, Verne J, Cooper A. Lifetime risk of being diagnosed with, or dying from, prostate cancer by major ethnic group in England 2008–2010. BMC Med. 2015 Jul 30;13(1):171.
- National Institute for Health and Care Excellence. Lower urinary tract symptoms in men: assessment and management. NICE Clinical Guideline 97 [Internet]. (modified June 2015); 2010. Available from: www.nice.org.uk/guidance/cg97
- National Institute for Health and Care Excellence. Prostate Cancer: diagnosis and treatment. Full guideline 175. 2014.
- National Institute for Health and Care Excellence. Suspected cancer: recognition and referral. NICE Guideline 12. June 2015, updated 2017. [Internet]. Available from: www.nice.org.uk/guidance/ng12/evidence/full-guidance-65700685
- Public Health England. Prostate cancer risk management programme (PCRMP): benefits and risks of PSA testing [Internet]. GOV.UK; 2016. Available from: www.gov.uk/government/publications/prostate-cancer-risk-management-programme-psa-test-benefits-and-risks/prostate-cancer-risk-management-programme-pcrmp-benefits-and-risks-of-psa-testing